BioWorld. Link to homepage.

Clarivate
  • BioWorld
  • BioWorld MedTech
  • BioWorld Asia
  • BioWorld Science
  • Data Snapshots
    • BioWorld
    • BioWorld MedTech
    • Infographics: Dynamic digital data analysis
    • Index insights
    • NME Digest
  • Special reports
    • Infographics: Dynamic digital data analysis
    • Trump administration impacts
    • Under threat: mRNA vaccine research
    • BioWorld at 35
    • Biopharma M&A scorecard
    • Bioworld 2025 review
    • BioWorld MedTech 2025 review
    • BioWorld Science 2025 review
    • Women's health
    • China's GLP-1 landscape
    • PFA re-energizes afib market
    • China CAR T
    • Alzheimer's disease
    • Coronavirus
    • More reports can be found here

BioWorld. Link to homepage.

  • Sign In
  • Sign Out
  • My Account
Subscribe
BioWorld - Monday, January 26, 2026
Home » Topics » Financings

Financings
Financings RSS Feed RSS

Financings for Oct. 21, 2024

Oct. 21, 2024
Biopharmas raising money in public or private financings, including: Bright Minds, Treeline.
Read More

Financings for October 21, 2024

Oct. 21, 2024
Med-tech firms raising money in public or private financings, including: Bioaffinity.
Read More
Brain with puzzle piece removed
Neurology/psychiatric

Series B financing at Seaport Therapeutics to advance neuropsychiatric pipeline

Oct. 21, 2024
Seaport Therapeutics Inc. has closed an oversubscribed $225 million series B financing round to support its work developing novel neuropsychiatric medicines.
Read More

Financings for Oct. 18, 2024

Oct. 18, 2024
Biopharmas raising money in public or private financings, including: Capricor, Curanex, Terray, Xortx.
Read More
3D dollar sign

Tencent invests $30M in Insighta to progress cancer diagnostics platform

Oct. 18, 2024
By Tamra Sami
China’s Tencent Technology Co. Ltd. has invested S30 million in Insighta Ltd., an early cancer detection company that was set up as a $200 million joint venture by Prenetics Global Ltd. and inventor Dennis Lo to revolutionize multi-cancer detection.
Read More

Financings for Oct. 17, 2024

Oct. 17, 2024
Biopharmas raising money in public or private financings, including: Arch Biopartners, Mid-Atlantic Biotherapeutics, Monument Therapeutics, Upstream Bio, Tennor Therapeutics.
Read More
Nyxoah Genio

Nyxoah raises $27M for US commercialization of sleep apnea technology​

Oct. 17, 2024
By Shani Alexander
Nyxoah SA recently raised $27 million after selling three million shares in a bid to shore up its capital base as it prepares to commercialize Genio — its obstructive sleep apnea technology — in the U.S.
Read More
Neurons with dendrites affected by amyloid plaques in Alzheimer's disease

Sunbird nabs $14M to progress blood test for Alzheimer’s​

Oct. 17, 2024
By Marian (YoonJee) Chu
Sunbird Bio Inc. closed an additional financing round of $14 million Oct. 16, reeling in new funding from Eli Lilly & Co. and the Singapore Economic Development Board’s investment arm, EDBI Pte Ltd.
Read More

Financings for October 17, 2024

Oct. 17, 2024
Med-tech firms raising money in public or private financings, including: Biocomposites, Horizon Surgical Systems, Infectotest, Minze Health, Oshi Health, Pip Care.
Read More

AI drug developer Aigen Sciences raises ₩12B series A

Oct. 16, 2024
By Marian (YoonJee) Chu
Backed by AI technology, Aigen Sciences Inc. raised ₩12 billion (US$8.8 million) in a series A financing round to further advance its cancer and rare disease drug pipelines.
Read More
Previous 1 2 … 122 123 124 125 126 127 128 129 130 … 647 648 Next

Popular Stories

  • Today's news in brief

    BioWorld
    BioWorld briefs for Jan 26, 2025.
  • Today's news in brief

    BioWorld MedTech
    BioWorld MedTech briefs for Jan. 23, 2026.
  • Illustration of magnifying glass inspecting brain

    Neurotrimin unveiled as marker in intellectual disability

    BioWorld Science
    Neurotrimin (NTM) is a member of the IgLON family, the disruption of which has been tied to emotional learning deficits and anxiety-like behavior in animal...
  • DNA mutations or genetic disorder concept art

    Biallelic variants in COX18 identified as cause of Charcot-Marie-Tooth disease

    BioWorld Science

    Charcot-Marie-Tooth (CMT) disease is a group of clinically and genetically heterogeneous sensorimotor peripheral neuropathies. It is the most frequent inherited...

  • Illustration of human body surrounded by DNA, cell and drug icons

    Cell/gene therapy sector now sustainable; China competition mounting

    BioWorld
    There was an upbeat message for cell and gene therapy companies in the 2026 industry update presented as the J.P. Morgan Healthcare Conference opened on Monday,...
  • BioWorld
    • Today's news
    • Analysis and data insight
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Newco news
    • Opinion
    • Regulatory
    • Science
  • BioWorld MedTech
    • Today's news
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Newco news
    • Opinion
    • Regulatory
    • Science
  • BioWorld Asia
    • Today's news
    • Analysis and data insight
    • Australia
    • China
    • Clinical
    • Deals and M&A
    • Financings
    • Newco news
    • Regulatory
    • Science
  • BioWorld Science
    • Today's news
    • Biomarkers
    • Cancer
    • Conferences
    • Endocrine/Metabolic
    • Immune
    • Infection
    • Neurology/Psychiatric
    • NME Digest
    • Patents
  • More
    • About
    • Advertise with BioWorld
    • Archives
    • Article reprints and permissions
    • Contact us
    • Cookie policy
    • Copyright notice
    • Data methodology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • Podcasts
    • Privacy policy
    • Share your news with BioWorld
    • Staff
    • Terms of use
    • Topic alerts
Follow Us

Copyright ©2026. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing